What is the recommended 10% weekly dose reduction plan for Ativan (lorazepam) for a patient taking 2mg, 4 times a week?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

10% Weekly Ativan Taper Schedule for 2mg Four Times Weekly

For a patient taking 2mg of Ativan (lorazepam) 4 times per week, a gradual 10% weekly reduction is recommended to minimize withdrawal symptoms and optimize patient outcomes.

Initial Assessment and Calculation

First, let's calculate the current weekly dose:

  • Current dose: 2mg × 4 times/week = 8mg total weekly dose

10% Weekly Reduction Schedule

Week Weekly Dose Individual Dose Frequency
1 (Current) 8mg 2mg 4 times/week
2 7.2mg 1.8mg 4 times/week
3 6.5mg ~1.6mg 4 times/week
4 5.9mg ~1.5mg 4 times/week
5 5.3mg ~1.3mg 4 times/week
6 4.8mg 1.2mg 4 times/week
7 4.3mg ~1.1mg 4 times/week
8 3.9mg ~1.0mg 4 times/week
9 3.5mg ~0.9mg 4 times/week
10 3.1mg ~0.8mg 4 times/week
11 2.8mg 0.7mg 4 times/week
12 2.5mg ~0.6mg 4 times/week
13 2.3mg ~0.6mg 4 times/week
14 2.1mg ~0.5mg 4 times/week
15 1.9mg ~0.5mg 4 times/week
16 1.7mg ~0.4mg 4 times/week
17 1.5mg ~0.4mg 4 times/week
18 1.4mg ~0.3mg 4 times/week
19 1.2mg 0.3mg 4 times/week
20 1.1mg ~0.3mg 4 times/week
21 1.0mg 0.25mg 4 times/week
22 0.9mg ~0.2mg 4 times/week
23 0.8mg 0.2mg 4 times/week
24 0.7mg ~0.2mg 4 times/week
25 0.6mg 0.15mg 4 times/week
26 0.5mg ~0.1mg 4 times/week
27 0.5mg ~0.1mg 4 times/week
28 0.4mg 0.1mg 4 times/week
29 0.4mg 0.1mg 4 times/week
30 0.3mg ~0.1mg 3 times/week
31 0.3mg 0.1mg 3 times/week
32 0.2mg ~0.1mg 2 times/week
33 0.2mg 0.1mg 2 times/week
34 0.1mg 0.1mg 1 time/week
35 Discontinue - -

Practical Implementation Tips

  1. Dose Preparation:

    • For doses that aren't commercially available, use the liquid formulation of lorazepam which allows for precise dosing 1
    • Mix with liquid or semi-solid food as directed in the FDA label
  2. Monitoring for Withdrawal Symptoms:

    • Common withdrawal symptoms include: anxiety, tremors, insomnia, irritability, nausea, headache, and muscle aches 2
    • If significant withdrawal symptoms occur, pause the taper and maintain the current dose for an additional week before resuming 1
  3. Adjustments:

    • If withdrawal symptoms are severe, slow the taper to 5% weekly reductions
    • For doses below 1mg, consider slowing to 5% reductions to minimize withdrawal symptoms

Important Considerations

  • This gradual taper is consistent with FDA recommendations to reduce the risk of withdrawal reactions 1
  • The 10% weekly reduction is supported by guidelines for benzodiazepine tapering 3
  • For practical purposes, some doses may need rounding to the nearest available formulation
  • Slower tapers (5-10% reduction) are generally better tolerated than more rapid tapers 3

Potential Pitfalls and Cautions

  • Avoid abrupt discontinuation which can lead to severe withdrawal symptoms including seizures
  • Be aware that withdrawal symptoms may be delayed, especially with longer-acting benzodiazepines 3
  • If the patient has been taking lorazepam for many years, an even slower taper (5% every 2-4 weeks) may be warranted
  • Consider adjunctive treatments for managing withdrawal symptoms if needed

This tapering schedule provides a structured approach to safely discontinue lorazepam while minimizing withdrawal symptoms and optimizing patient outcomes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.